News

Merck & Co. (MRK) Announces that US FDA Approves ENFLONSIA™ For Preventing RSV Lower Respiratory Tract Disease
Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that ...
MedPage Today on MSN22h
CDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV Shot
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
Kennedy Expands RSV Vaccine Recommendations. Moderna, Pfizer Shares Are Up.
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...